Published in AIDS Weekly, December 13th, 1999
HIV-1 resistance to protease inhibitors is associated with HIV-1 mutations. Over time, unique combinations of mutations in individual patients arise, depending on the therapeutic regimen used, noted C. Blumtritt and colleagues, Union Against STD, Buenos Aires, Argentina.
Blumtritt et al. presented their study, titled "Protease Inhibitors (PIs) Resistance to HIV-1 Demonstrated by Genotyping," at the Seventh Latin-American Congress on Sexually Transmitted Diseases held September 8-11,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.